These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 3052266)

  • 1. A crossover trial of bromocriptine in the treatment of vascular dementia.
    Nadeau SE; Malloy PF; Andrew ME
    Ann Neurol; 1988 Aug; 24(2):270-2. PubMed ID: 3052266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease.
    Castro-Caldas A; Delwaide P; Jost W; Merello M; Williams A; Lamberti P; Aguilar M; Del Signore S; Cesaro P;
    Mov Disord; 2006 Apr; 21(4):500-9. PubMed ID: 16267842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome.
    Walters AS; Hening WA; Kavey N; Chokroverty S; Gidro-Frank S
    Ann Neurol; 1988 Sep; 24(3):455-8. PubMed ID: 3067654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose bromocriptine in the early phases of Parkinson's disease.
    Tolosa E; Blesa R; Bayes A; Forcadell F
    Clin Neuropharmacol; 1987 Apr; 10(2):168-74. PubMed ID: 3332610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A neuropsychological test battery for use in Alzheimer disease clinical trials.
    Harrison J; Minassian SL; Jenkins L; Black RS; Koller M; Grundman M
    Arch Neurol; 2007 Sep; 64(9):1323-9. PubMed ID: 17846273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease.
    Leroi I; Brandt J; Reich SG; Lyketsos CG; Grill S; Thompson R; Marsh L
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):1-8. PubMed ID: 14716693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selegiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. Czech and Slovak Senile Dementia of Alzheimer Type Study Group.
    Filip V; Kolibás E
    J Psychiatry Neurosci; 1999 May; 24(3):234-43. PubMed ID: 10354658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of bromocriptine in senile dementia].
    Borenstein P; Soret C; Graille D
    Ann Med Psychol (Paris); 1981 Mar; 139(3):326-34. PubMed ID: 7325489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiopulmonary bypass, temperature, and central nervous system dysfunction.
    McLean RF; Wong BI; Naylor CD; Snow WG; Harrington EM; Gawel M; Fremes SE
    Circulation; 1994 Nov; 90(5 Pt 2):II250-5. PubMed ID: 7955261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and assessment of a neuropsychological battery to aid in predicting driving performance.
    Szlyk JP; Myers L; Zhang Y; Wetzel L; Shapiro R
    J Rehabil Res Dev; 2002; 39(4):483-96. PubMed ID: 17638145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind trial of bromocriptine efficacy in nonfluent aphasia after stroke.
    Ashtary F; Janghorbani M; Chitsaz A; Reisi M; Bahrami A
    Neurology; 2006 Mar; 66(6):914-6. PubMed ID: 16567711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and neuropsychological study with oxiracetam versus placebo in patients with mild to moderate dementia.
    Villardita C; Parini J; Grioli S; Quattropani M; Lomeo C; Scapagnini U
    J Neural Transm Suppl; 1987; 24():293-8. PubMed ID: 3479527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral physostigmine in Alzheimer's disease.
    Stern Y; Sano M; Mayeux R
    Ann Neurol; 1987 Sep; 22(3):306-10. PubMed ID: 3674795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study.
    Poewe W; Wolters E; Emre M; Onofrj M; Hsu C; Tekin S; Lane R;
    Mov Disord; 2006 Apr; 21(4):456-61. PubMed ID: 16229010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine improves reduced libido and potency in men receiving maintenance hemodialysis.
    Muir JW; Besser GM; Edwards CR; Rees LH; Cattell WR; Ackrill P; Baker LR
    Clin Nephrol; 1983 Dec; 20(6):308-14. PubMed ID: 6357576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dystonia: treatment with bromocriptine.
    Newman RP; LeWitt PA; Shults C; Bruno G; Foster NL; Chase TN; Calne DB
    Clin Neuropharmacol; 1985; 8(4):328-33. PubMed ID: 3907823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial.
    Nutt JG; Carter JH; Carlson NE
    Arch Neurol; 2007 Mar; 64(3):319-23. PubMed ID: 17353373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuropsychological findings in adults with attention deficit hyperactivity disorder].
    Oncü B; Olmez S
    Turk Psikiyatri Derg; 2004; 15(1):41-6. PubMed ID: 15095114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.